My ePortfolio Register   

AACR 2014 /
Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.05.14
Views: 1679
Rating:

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA

Dr Garrett talks to ecancertv at the AACR conference about her work surrounding HER2-targeted therapies and the ways in which resistance to treatment might be overcome by paying particular attention to fibroblast growth factor receptors (FGFRs) in strategies against breast cancer.

Read the article for more. 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence